Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, ...
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...
AZoLifeSciences on MSN
GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery
GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...
And although existing humanized mouse models have B cells, they fail to mount a strong enough antibody response, creating what Voss calls a “developmental block”. THX mice overcome this limitation, ...
NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
TipRanks on MSN
Karolinska Development’s SVF Vaccines Shows Promising Preclinical Results for Hepatitis Treatment
An announcement from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development AB’s portfolio company, SVF Vaccines, has ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
Cedars-Sinai researchers created “young” immune cells from human stem cells that reversed cognitive decline and Alzheimer’s ...
Researchers unpick the neural mechanisms of how hunger and hormones lead to aggressive behaviours in mice — plus, what gen-AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback